Aromasin 25 mg
Aromasin 25 mg is a medicine authorised by Swissmedic under authorisation number 55216. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 October 1999 and the authorisation is valid without a time limit. ATC code L02BG06 places the medicine in the group Endocrine therapy.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Aromasin 25 mg, überzogene Tabletten | B | 14 October 1999 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 30 | Dragée(s) | L02BG06 | 07.16.2. | B |
| 6 | 100 | Dragée(s) | L02BG06 | 07.16.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Aromasin 25 mg authorised in Switzerland?
Yes. Aromasin 25 mg is authorised by Swissmedic under authorisation number 55216, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Aromasin 25 mg have?
Aromasin 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Aromasin 25 mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.